We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




用无创尿检检测前列腺癌

By LabMedica International staff writers
Posted on 17 Apr 2018
Print article
CellDetect平台是唯一能在形态检查的同时区分正常细胞、癌变前细胞与癌细胞颜色的组织化学解决方案(图片蒙Micromedic Technologies公司惠赐)。
CellDetect平台是唯一能在形态检查的同时区分正常细胞、癌变前细胞与癌细胞颜色的组织化学解决方案(图片蒙Micromedic Technologies公司惠赐)。

前列腺癌是世界上男性第二常见的癌症。大概每九个男子中就有一人在一生中被诊断出前列腺癌。据估计,2018年美国将有约165千例前列腺癌新发病例,致死约29,000例。

 

前列腺癌原先通过直肠指检诊断,如果医生发现前列腺组织、形状或大小的任何异常,就需要让患者做进一步检验。前列腺特异抗原(PSA)检验被用来分析血样中是否有前列腺自然产生的一种物质。

 

以色列雷霍沃特市开普兰医疗中心的科学家开展的一项临床研究包括59份尿样(来自28名前列腺癌阳性患者与31名健康对照者),一名细胞病理学家用以色列特拉维夫Micromedic Technologies公司CellDetect独一颜色标记物检查过这些样本。CellDetect是新一代细胞病理染色平台,可准确检测癌症。它基于颜色与形态的独特组合提供专利型诊断解决方案。多项临床研究已证明CellDetect检测宫颈癌与膀胱癌的效力,据估计,这项技术还可用于检测别的癌症。

 

科研小组发现,所检验的59份样本中,高达80%得到明确诊断并相应出现在临床研究结果中。比较前列腺癌阳性患者的结果与临床研究前这些患者的活检结果。结果表明Micromedic公司的产品成功检测到尿样中的前列腺癌细胞,灵敏度高达91.3%,特异性为75%

 

Micromedic公司CEO、工商管理硕士Guy Lerner说:这项临床研究的结果令我们非常高兴,它说明CellDetect技术有望显著改进前列腺癌的诊断。虽然前列腺癌是世界上男性第二常见的癌症,但是我们知道现有的诊断检验不可靠。有了这些临床研究的结果,我们确信我们的产品有望颠覆前列腺癌诊断,为患者提供一种准确可靠的无创检验,通过节省可观的医疗费改良卫生系统。


Related Links:
开普兰医疗中心>>> www.clalit-global.co.il
Micromedic Technologies >>> www.m-medic.com

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.